Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 2.186
+0.016 (0.74%)
Jul 3, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 543.47 million as of July 2, 2026. Its market cap has increased by 100.18% in one year.
Market Cap
543.47M
Enterprise Value
285.43M
Revenue
317.21M
Ranking
n/a
PE Ratio
3.42
Stock Price
2.19
Market Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 543.47M, an increase of 350.81%. That is a compound annual growth rate of 14.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 543.47M | -47.77% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.09B |
| Infant Bacterial Therapeutics AB | 943.00M |
| Xspray Pharma AB | 701.77M |
| FluoGuide | 686.67M |
| Oncopeptides AB | 641.16M |
| Corline Biomedical AB | 469.09M |
| AlzeCure Pharma AB | 444.72M |
| Intervacc AB | 444.42M |